Related Experiment Video
Updated: Jul 19, 2025

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection
Yan Yan1, Yuanwang Qiu1, Chantsalmaa Davgadorj1
1Laboratory for Infection and Immunity, Hepatology Institute of Wuxi, The Fifth People's Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China.
Abstract:
[This corrects the article DOI: 10.3389/fcimb.2022.847539.].
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Viruses with RNA Genomes
Microorganisms in Medicine and Therapeutics
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...